Results 201 to 210 of about 12,413,959 (307)

Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany. [PDF]

Pharmacoecon Open
Meier N, Fuchs H, Galactionova K, Hermans C, Pletscher M, Schwenkglenks M.   +5 more
europepmc   +1 more source

A Case Report of Non‐Neutralizing Acquired Factor V Inhibitor Mimicking Deficiency: Diagnostic Challenges and Therapeutic Implications

Case Reports in Hematology, Volume 2026, Issue 1, 2026.
Acquired Factor V (FV) deficiency due to inhibitors is a rare coagulopathy that presents significant diagnostic and therapeutic challenges. We report the case of an 81‐year‐old male with persistent gross hematuria and severe coagulopathy, marked by prolonged prothrombin time (PT), activated partial thromboplastin time (aPTT), and critically low FV ...
Shreyas Kalantri, Pranali Pachika, Shiva Balasubramanian, Bayan Alquran, Morgan McCoy, Vivek Sharma, Andrew Song   +6 more
wiley   +1 more source

Home treatment of haemarthrosis with recombinant activated factor VII in patients with haemophilia A or B and inhibitors

, 2016
Meriem Bensadok, Abdulkareem Al-Momen, A. Alzoebie, Soraya Benchikh El Fegoun, Yasser Wali, Fati Hamzy, Nemra Mehalhal, Fatiha Grifi, Selma Hamdi, Naïma Mesli, Tarek Owaidah, Hossam Saad, Nouredine Sidi Mansour, Hadj Touhami   +13 more
openalex   +1 more source

The Use of Tranexamic Acid to Treat Melasma: A Systematic Review and Meta‐Analysis

Dermatologic Therapy, Volume 2026, Issue 1, 2026.
Introduction Tranexamic acid (TXA) is a synthetic derivative of the amino acid lysine that inhibits bleeding due to its effects on plasminogen conversion, approved by the FDA to treat menorrhagia and prevent bleeding in hemophilia patients undergoing dental extraction.
Nabila Scabine Pessotti, Vinicius Tassoni Civile, Talita Andrade Brandao, Felipe Ribeiro, Gisele Viana de Oliveira, Nathalia Sernizon Guimarães, Denise Steiner, Mahlatse Kgokolo   +7 more
wiley   +1 more source

Correction to: Nonacog Beta Pegol: A Review in Haemophilia B. [PDF]

Drugs, 2018
Syed YY.
europepmc   +1 more source

Real-World Utilisation and Bleed Rates in Patients with Haemophilia B Who Switched to Recombinant Factor IX Fusion Protein (rIX-FP): A Retrospective International Analysis. [PDF]

Adv Ther, 2020
Hermans C, Marino R, Lambert C, Mangles S, Sommerer P, Rives V, Maro G, Malcangi G.   +7 more
europepmc   +1 more source

Nonacog Beta Pegol: A Review in Haemophilia B. [PDF]

Drugs, 2017
Syed YY.
europepmc   +1 more source

Haemophilia A/B carriers: haemorrhagic burden of disease and open issues.

, 2020
Samantha Pasca, Ezio Zanon
openalex   +2 more sources

Intraventricular haemorrhage and obstructive hydrocephalus in a term neonate: an uncommon presentation of haemophilia B. [PDF]

BMJ Case Rep, 2018
Bhattacharya D, Sharawat IK, Saini L.
europepmc   +1 more source

Thrombogenicity evaluation in 221 patients with haemophilia B treated with nonacog alfa. [PDF]

Blood Coagul Fibrinolysis, 2018
Rendo P, Lamb J, Smith L, Fuiman J, Korth-Bradley JM.   +4 more
europepmc   +1 more source